A study led by University of North Carolina at Chapel Hill School of Medicine researchers has shown that the investigational new drug liraglutide taken once daily may be safer and more effective than currently available medications for people with type...

The U.S. Food and Drug Administration today approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high blood sugar levels.